| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.2 | 7e-10 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | 0.22 | 2e-08 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-08 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.26 | 4e-08 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.18 | 1e-07 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-07 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | 0.2 | 3e-07 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.17 | 8e-07 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-06 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-06 |